1Korea Central Cancer Registry, National Cancer Center, Goyang, Korea
2Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea
3National Cancer Control Institute, National Cancer Center, Goyang, Korea
4National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
Copyright © 2023 by the Korean Cancer Association
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Author Contributions
Conceived and designed the analysis: Jung KW.
Collected the data: Jung KW, Regional Cancer Registry Committee.
Contributed data or analysis tools: Kang MJ, Jung KW, Kong HJ, Kim HJ, Park EH, Yun EH.
Performed the analysis: Bang SH, Choi SH
Wrote the paper: Kang MJ, Jung KW.
Interpretation and review: Jung KW, Kong HJ.
Review and comment: Im JS, Seo HG.
Conflicts of Interest
Conflict of interest relevant to this article was not reported.
Site/Type | New cases | Deaths | Prevalent casesa) | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
Both sexes | Men | Women | Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 247,952 | 130,618 | 117,334 | 82,204 | 50,817 | 31,387 | 2,276,792 | 998,948 | 1,277,844 |
|
|||||||||
Lip, oral cavity, and pharynx | 4,064 | 2,892 | 1,172 | 1,283 | 972 | 311 | 31,447 | 20,948 | 10,499 |
|
|||||||||
Esophagus | 2,748 | 2,451 | 297 | 1,564 | 1,404 | 160 | 12,684 | 11,274 | 1,410 |
|
|||||||||
Stomach | 26,662 | 17,869 | 8,793 | 7,510 | 4,807 | 2,703 | 330,217 | 217,881 | 112,336 |
|
|||||||||
Colon and rectum | 27,877 | 16,485 | 11,392 | 8,869 | 5,029 | 3,840 | 292,586 | 173,285 | 119,301 |
|
|||||||||
Liver | 15,152 | 11,150 | 4,002 | 10,565 | 7,812 | 2,753 | 77,958 | 58,239 | 19,719 |
|
|||||||||
Gallbladderb) | 7,452 | 4,012 | 3,440 | 5,192 | 2,784 | 2,408 | 26,685 | 13,770 | 12,915 |
|
|||||||||
Pancreas | 8,414 | 4,324 | 4,090 | 6,775 | 3,452 | 3,323 | 16,415 | 8,293 | 8,122 |
|
|||||||||
Larynx | 1,203 | 1,141 | 62 | 321 | 310 | 11 | 12,251 | 11,524 | 727 |
|
|||||||||
Lung | 28,949 | 19,657 | 9,292 | 18,673 | 13,824 | 4,849 | 111,208 | 66,240 | 44,968 |
|
|||||||||
Breast | 24,923 | 117 | 24,806 | 2,745 | 20 | 2,725 | 279,965 | 1,012 | 278,953 |
|
|||||||||
Cervix uteri | 2,998 | - | 2,998 | 810 | - | 810 | 60,467 | - | 60,467 |
|
|||||||||
Corpus uteri | 3,492 | - | 3,492 | 378 | - | 378 | 33,785 | - | 33,785 |
|
|||||||||
Ovary | 2,947 | - | 2,947 | 1,369 | - | 1,369 | 25,683 | - | 25,683 |
|
|||||||||
Prostate | 16,815 | 16,815 | - | 2,194 | 2,194 | - | 120,423 | 120,423 | - |
|
|||||||||
Testis | 361 | 361 | - | 14 | 14 | - | 4,385 | 4,385 | - |
|
|||||||||
Kidney | 5,946 | 4,135 | 1,811 | 1,076 | 764 | 312 | 54,652 | 36,986 | 17,666 |
|
|||||||||
Bladder | 4,753 | 3,826 | 927 | 1,593 | 1,235 | 358 | 41,835 | 34,085 | 7,750 |
|
|||||||||
Brain and CNS | 1,970 | 1,056 | 914 | 1,437 | 784 | 653 | 13,411 | 6,888 | 6,523 |
|
|||||||||
Thyroid | 29,180 | 7,458 | 21,722 | 365 | 128 | 237 | 489,688 | 91,546 | 398,142 |
|
|||||||||
Hodgkin lymphoma | 323 | 214 | 109 | 48 | 30 | 18 | 3,657 | 2,255 | 1,402 |
|
|||||||||
Non-Hodgkin lymphoma | 5,636 | 3,248 | 2,388 | 1,926 | 1,106 | 820 | 40,853 | 23,163 | 17,690 |
|
|||||||||
Multiple myeloma | 1,747 | 961 | 786 | 976 | 514 | 462 | 8,307 | 4,381 | 3,926 |
|
|||||||||
Leukemia | 3,605 | 2,020 | 1,585 | 1,825 | 1,048 | 777 | 27,157 | 15,045 | 12,112 |
|
|||||||||
Other and ill-defined | 20,735 | 10,426 | 10,309 | 4,696 | 2,586 | 2,110 | 161,073 | 77,325 | 83,748 |
CNS, central nervous system.
a) Limited-duration prevalent cases on January 1, 2020. These are patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times,
b) Includes the gallbladder and other/unspecified parts of the biliary tract.
Site/Type | Crude incidence rate per 100,000 | Age-standardized incidence rate per 100,000a) | ||||
---|---|---|---|---|---|---|
|
|
|||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 482.9 | 510.1 | 455.8 | 262.2 | 279.1 | 257.3 |
|
||||||
Lip, oral cavity, and pharynx | 7.9 | 11.3 | 4.6 | 4.4 | 6.4 | 2.6 |
|
||||||
Esophagus | 5.4 | 9.6 | 1.2 | 2.6 | 4.9 | 0.5 |
|
||||||
Stomach | 51.9 | 69.8 | 34.2 | 25.7 | 36.9 | 15.9 |
|
||||||
Colon and rectum | 54.3 | 64.4 | 44.3 | 27.1 | 34.8 | 20.2 |
|
||||||
Liver | 29.5 | 43.5 | 15.5 | 14.5 | 23.2 | 6.7 |
|
||||||
Gallbladderb) | 14.5 | 15.7 | 13.4 | 6.2 | 7.7 | 4.9 |
|
||||||
Pancreas | 16.4 | 16.9 | 15.9 | 7.6 | 8.7 | 6.7 |
|
||||||
Larynx | 2.3 | 4.5 | 0.2 | 1.1 | 2.3 | 0.1 |
|
||||||
Lung | 56.4 | 76.8 | 36.1 | 25.8 | 38.5 | 15.9 |
|
||||||
Breast | 48.5 | 0.5 | 96.4 | 30.1 | 0.2 | 59.9 |
|
||||||
Cervix uteri | 5.8 | - | 11.6 | 3.7 | - | 7.3 |
|
||||||
Corpus uteri | 6.8 | - | 13.6 | 4.2 | - | 8.4 |
|
||||||
Ovary | 5.7 | - | 11.4 | 3.5 | - | 7.0 |
|
||||||
Prostate | 32.7 | 65.7 | - | 14.7 | 32.5 | - |
|
||||||
Testis | 0.7 | 1.4 | - | 0.7 | 1.4 | - |
|
||||||
Kidney | 11.6 | 16.1 | 7.0 | 6.6 | 9.4 | 3.9 |
|
||||||
Bladder | 9.3 | 14.9 | 3.6 | 4.1 | 7.5 | 1.4 |
|
||||||
Brain and CNS | 3.8 | 4.1 | 3.6 | 2.8 | 3.2 | 2.4 |
|
||||||
Thyroid | 56.8 | 29.1 | 84.4 | 41.3 | 20.9 | 62.4 |
|
||||||
Hodgkin lymphoma | 0.6 | 0.8 | 0.4 | 0.5 | 0.7 | 0.4 |
|
||||||
Non-Hodgkin lymphoma | 11.0 | 12.7 | 9.3 | 6.6 | 8.1 | 5.2 |
|
||||||
Multiple myeloma | 3.4 | 3.8 | 3.1 | 1.6 | 1.9 | 1.4 |
|
||||||
Leukemia | 7.0 | 7.9 | 6.2 | 5.4 | 6.1 | 4.8 |
|
||||||
Other and ill-defined | 40.4 | 40.7 | 40.0 | 21.4 | 23.7 | 19.4 |
Rank | Cause of death | No. of deaths | Percentage of all deaths | Age-standardized death rate per 100,000a) |
---|---|---|---|---|
All causes | 304,948 | 100.0 | 249.4 | |
1 | Cancer | 82,204 | 27.0 | 69.9 |
2 | Heart disease | 32,347 | 10.6 | 24.2 |
3 | Cerebrovascular disease | 21,860 | 7.2 | 16.2 |
4 | Pneumonia | 22,257 | 7.3 | 14.8 |
5 | Intentional self-harm (suicide) | 13,195 | 4.3 | 17.9 |
6 | Diabetes mellitus | 8,456 | 2.8 | 6.3 |
7 | Disease of liver | 6,979 | 2.3 | 7.1 |
8 | Chronic lower respiratory diseases | 5,668 | 1.9 | 3.8 |
9 | Hypertensive diseases | 6,100 | 2.0 | 4.0 |
10 | Transport accidents | 3,947 | 1.3 | 4.6 |
Others | 101,935 | 33.4 | 80.5 |
Source: Mortality Data, 2020, Statistics Korea [2].
a) Age-adjusted using the Segi’s world standard population.
Site/Type | Crude mortality rate per 100,000 | Age-standardized mortality rate per 100,000a) | ||||
---|---|---|---|---|---|---|
|
|
|||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 160.1 | 198.5 | 121.9 | 69.9 | 99.4 | 47.8 |
|
||||||
Lip, oral cavity, and pharynx | 2.5 | 3.8 | 1.2 | 1.2 | 2.0 | 0.5 |
|
||||||
Esophagus | 3.0 | 5.5 | 0.6 | 1.4 | 2.7 | 0.3 |
|
||||||
Stomach | 14.6 | 18.8 | 10.5 | 6.4 | 9.5 | 4.1 |
|
||||||
Colon and rectum | 17.3 | 19.6 | 14.9 | 7.2 | 9.9 | 5.2 |
|
||||||
Liver | 20.6 | 30.5 | 10.7 | 9.4 | 15.7 | 3.9 |
|
||||||
Gallbladderb) | 10.1 | 10.9 | 9.4 | 4.0 | 5.2 | 3.1 |
|
||||||
Pancreas | 13.2 | 13.5 | 12.9 | 5.7 | 6.8 | 4.7 |
|
||||||
Larynx | 0.6 | 1.2 | 0.0 | 0.3 | 0.6 | 0.0 |
|
||||||
Lung | 36.4 | 54.0 | 18.8 | 14.9 | 25.9 | 6.6 |
|
||||||
Breast | 5.3 | 0.1 | 10.6 | 2.9 | 0.0 | 5.6 |
|
||||||
Cervix uteri | 1.6 | - | 3.1 | 0.8 | - | 1.5 |
|
||||||
Corpus uteri | 0.7 | - | 1.5 | 0.4 | - | 0.7 |
|
||||||
Ovary | 2.7 | - | 5.3 | 1.3 | - | 2.6 |
|
||||||
Prostate | 4.3 | 8.6 | - | 1.5 | 4.0 | - |
|
||||||
Testis | 0.0 | 0.1 | - | 0.0 | 0.0 | - |
|
||||||
Kidney | 2.1 | 3.0 | 1.2 | 0.9 | 1.5 | 0.4 |
|
||||||
Bladder | 3.1 | 4.8 | 1.4 | 1.2 | 2.3 | 0.4 |
|
||||||
Brain and CNS | 2.8 | 3.1 | 2.5 | 1.6 | 1.9 | 1.3 |
|
||||||
Thyroid | 0.7 | 0.5 | 0.9 | 0.3 | 0.2 | 0.3 |
|
||||||
Hodgkin lymphoma | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 |
|
||||||
Non-Hodgkin lymphoma | 3.8 | 4.3 | 3.2 | 1.7 | 2.3 | 1.2 |
|
||||||
Multiple myeloma | 1.9 | 2.0 | 1.8 | 0.8 | 1.0 | 0.6 |
|
||||||
Leukemia | 3.6 | 4.1 | 3.0 | 1.9 | 2.4 | 1.5 |
|
||||||
Other and ill-defined | 9.1 | 10.1 | 8.2 | 4.2 | 5.5 | 3.2 |
Site/Type | Incidence | Mortality | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||||||
1999 | 2020 | Trend 1 | Trend 2 | Trend 3 | 1999 | 2020 | Trend 1 | Trend 2 | Trend 3 | |||||||
|
|
|
|
|
|
|||||||||||
Years | APC | Years | APC | Years | APC | Years | APC | Years | APC | Years | APC | |||||
All sites | 212.1 | 262.2 | 1999–2012 | 3.3a) | 2012–2015 | −5.0a) | 2015–2020 | 0.3 | 115.1 | 69.9 | 1999–2002 | 0.9 | 2002–2013 | −2.7a) | 2013–2020 | −3.3a) |
|
||||||||||||||||
Lip, oral cavity, and pharynx | 3.6 | 4.4 | 1999–2020 | 0.7a) | - | - | - | - | 1.1 | 1.2 | 1999–2020 | −1.8a) | - | - | - | - |
|
||||||||||||||||
Esophagus | 4.1 | 2.6 | 1999–2020 | −2.0a) | - | - | - | - | 3.1 | 1.4 | 1999–2020 | −4.3a) | - | - | - | - |
|
||||||||||||||||
Stomach | 43.6 | 25.7 | 1999–2011 | −0.2 | 2011–2020 | −4.8a) | - | - | 23.9 | 6.4 | 1999–2002 | −2.5a) | 2002–2010 | −6.4a) | 2010–2020 | −7.2a) |
|
||||||||||||||||
Colon and rectum | 20.5 | 27.1 | 1999–2006 | 7.3a) | 2006–2011 | 2.9a) | 2011–2020 | −3.8a) | 7.8 | 7.2 | 1999–2003 | 6.5a) | 2003–2012 | −0.5a) | 2012–2020 | −3.6a) |
|
||||||||||||||||
Liver | 27.9 | 14.5 | 1999–2010 | −1.7a) | 2010–2020 | −4.3a) | - | - | 20.6 | 9.4 | 1999–2002 | 0.6 | 2002–2014 | −3.7a) | 2014–2020 | −5.9a) |
|
||||||||||||||||
Gallbladderb) | 6.5 | 6.2 | 1999–2004 | 1.4 | 2004–2018 | −0.3 | 2018–2020 | −3.6 | 5.2 | 4.0 | 1999–2001 | 7.7 | 2001–2013 | −2.9a) | 2013–2020 | −0.7 |
|
||||||||||||||||
Pancreas | 5.6 | 7.6 | 1999–2020 | 1.6a) | - | - | - | - | 5.5 | 5.7 | 1999–2020 | 0.1 | - | - | - | - |
|
||||||||||||||||
Larynx | 2.4 | 1.1 | 1999–2020 | −3.5a) | - | - | - | - | 1.6 | 0.3 | 1999–2005 | −8.1a) | 2005–2008 | −15.5a) | 2008–2020 | −7.2a) |
|
||||||||||||||||
Lung | 28.5 | 25.8 | 1999–2020 | −0.3a) | - | - | - | - | 22.5 | 14.9 | 1999–2001 | 3.6 | 2001–2013 | −1.9a) | 2013–2020 | −3.6a) |
|
||||||||||||||||
Breast | 11.0 | 30.1 | 1999–2008 | 6.3a) | 2008–2020 | 4.1a) | - | - | 2.3 | 2.9 | 1999–2004 | 2.9a) | 2004–2020 | 0.8a) | - | - |
|
||||||||||||||||
Cervix uteri | 8.6 | 3.7 | 1999–2007 | −4.6a) | 2007–2020 | −3.2a) | - | - | 1.4 | 0.8 | 1999–2003 | 10.1a) | 2003–2008 | −7.1a) | 2008–2020 | −4.2a) |
|
||||||||||||||||
Corpus uteri | 1.4 | 4.2 | 1999–2020 | 5.1a) | - | - | - | - | 0.1 | 0.4 | 1999–2003 | 36.1a) | 2003–2020 | 2.3a) | - | - |
|
||||||||||||||||
Ovary | 2.7 | 3.5 | 1999–2020 | 1.7a) | - | - | - | - | 0.9 | 1.3 | 1999–2020 | 0.6a) | - | - | - | |
|
||||||||||||||||
Prostate | 3.1 | 14.7 | 1999–2009 | 14.8a) | 2009–2015 | 1 | 2015–2020 | 5.6a) | 0.9 | 1.5 | 1999–2002 | 15.0a) | 2002–2010 | 1.9a) | 2010–2020 | −1.1a) |
|
||||||||||||||||
Testis | 0.3 | 0.7 | 1999–2020 | 4.8a) | - | - | - | - | 0.0 | 0.0 | 1999–2020 | −2.4a) | - | - | - | - |
|
||||||||||||||||
Kidney | 3.0 | 6.6 | 1999–2009 | 6.4a) | 2009–2020 | 2.2a) | - | - | 1.1 | 0.9 | 1999–2016 | −0.2 | 2016–2020 | −4.7a) | - | - |
|
||||||||||||||||
Bladder | 4.7 | 4.1 | 1999–2004 | 1.9 | 2004–2020 | −1.1a) | - | - | 1.3 | 1.2 | 1999–2002 | 9.3a) | 2002–2005 | −6.0 | 2005–2020 | −1.5a) |
|
||||||||||||||||
Brain and CNS | 2.9 | 2.8 | 1999–2020 | 0.1 | - | - | - | - | 1.9 | 1.6 | 1999–2003 | 4.1a) | 2003–2008 | −4.3a) | 2008–2020 | −0.8a) |
|
||||||||||||||||
Thyroid | 6.5 | 41.3 | 1999–2011 | 22.4a) | 2011–2016 | −12.1a) | 2016–2020 | 4.5 | 0.4 | 0.3 | 1999–2003 | 7.4a) | 2003–2020 | −4.5a) | - | - |
|
||||||||||||||||
Hodgkin lymphoma | 0.3 | 0.5 | 1999–2011 | 4.9a) | 2011–2020 | 1.6 | - | - | 0.0 | 0.0 | 1999–2004 | 24.7a) | 2004–2020 | −2.6a) | - | - |
|
||||||||||||||||
Non-Hodgkin lymphoma | 4.3 | 6.6 | 1999–2020 | 2.3a) | - | - | - | - | 2.1 | 1.7 | 1999–2020 | −1.1a) | - | - | - | - |
|
||||||||||||||||
Multiple myeloma | 1.0 | 1.6 | 1999–2013 | 3.7a) | 2013–2020 | 0.3 | - | - | 0.6 | 0.8 | 1999–2003 | 12.8a) | 2003–2016 | 0.8 | 2016–2020 | −6.0a) |
|
||||||||||||||||
Leukemia | 4.7 | 5.4 | 1999–2020 | 0.9a) | - | - | - | - | 2.9 | 1.9 | 1999–2020 | −1.9a) | - | - | - | - |
|
||||||||||||||||
Other and ill-defined | 15.0 | 21.4 | 1999–2018 | 2.3a) | 2018–2020 | −2.1 | - | - | 7.8 | 4.2 | 1999–2020 | −2.7a) | - | - | - | - |
Site/Type | Both sexes | Men | Women | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||||||||||||
1993–1995 | 1996–2000 | 2001–2005 | 2006–2010 | 2011–2015 | 2016–2020 | Changea) | 1993–1995 | 1996–2000 | 2001–2005 | 2006–2010 | 2011–2015 | 2016–2020 | Changea) | 1993–1995 | 1996–2000 | 2001–2005 | 2006–2010 | 2011–2015 | 2016–2020 | Changea) | |
All sites | 42.9 | 45.2 | 54.1 | 65.5 | 70.7 | 71.5 | 28.6 | 33.2 | 36.4 | 45.6 | 56.9 | 63.1 | 65.5 | 32.3 | 55.2 | 56.4 | 64.3 | 74.4 | 78.3 | 77.8 | 22.6 |
|
|||||||||||||||||||||
All sites excluding thyroid | 41.2 | 43.4 | 50.9 | 59.1 | 64.3 | 67.3 | 26.1 | 32.7 | 35.9 | 44.7 | 54.6 | 60.4 | 63.4 | 30.7 | 52.6 | 53.5 | 59.1 | 65.0 | 69.4 | 72.2 | 19.6 |
|
|||||||||||||||||||||
Lip, oral cavity, and pharynx | 42.2 | 47.4 | 54.5 | 61.1 | 65.5 | 69.4 | 27.2 | 36.6 | 41.7 | 49.7 | 56.9 | 61.8 | 66.7 | 30.1 | 59.4 | 64.5 | 68.1 | 72.1 | 74.5 | 75.8 | 16.5 |
|
|||||||||||||||||||||
Esophagus | 14.0 | 15.7 | 21.6 | 30.0 | 36.6 | 42.2 | 28.2 | 13.0 | 14.7 | 20.8 | 29.4 | 36.2 | 41.8 | 28.7 | 25.0 | 25.9 | 29.8 | 37.3 | 39.6 | 45.6 | 20.6 |
|
|||||||||||||||||||||
Stomach | 43.9 | 47.3 | 58.0 | 68.4 | 75.9 | 78.0 | 34.1 | 44.0 | 47.6 | 58.7 | 69.1 | 76.8 | 78.9 | 35.0 | 43.7 | 46.8 | 56.6 | 67.0 | 74.0 | 76.0 | 32.3 |
|
|||||||||||||||||||||
Colon and rectum | 56.2 | 58.9 | 66.9 | 73.9 | 76.1 | 74.3 | 18.1 | 56.7 | 59.8 | 68.8 | 75.8 | 77.8 | 75.6 | 19.0 | 55.7 | 57.7 | 64.5 | 71.1 | 73.6 | 72.3 | 16.7 |
|
|||||||||||||||||||||
Liver | 11.8 | 14.1 | 20.5 | 28.3 | 34.4 | 38.7 | 26.9 | 10.8 | 13.8 | 20.4 | 28.3 | 35.0 | 39.1 | 28.2 | 15.1 | 15.1 | 20.9 | 28.3 | 32.8 | 37.6 | 22.6 |
|
|||||||||||||||||||||
Gallbladderb) | 18.7 | 20.7 | 23.1 | 26.9 | 28.8 | 29.0 | 10.4 | 18.0 | 21.1 | 23.5 | 27.8 | 29.5 | 29.8 | 11.7 | 19.3 | 20.3 | 22.7 | 26.0 | 28.0 | 28.2 | 8.9 |
|
|||||||||||||||||||||
Pancreas | 10.6 | 8.7 | 8.4 | 8.6 | 10.9 | 15.2 | 4.6 | 10.0 | 8.3 | 8.4 | 8.3 | 10.3 | 14.2 | 4.2 | 11.5 | 9.3 | 8.4 | 8.9 | 11.6 | 16.2 | 4.7 |
|
|||||||||||||||||||||
Larynx | 61.6 | 63.3 | 66.5 | 73.2 | 75.3 | 80.0 | 18.3 | 62.2 | 63.7 | 67.1 | 73.5 | 75.7 | 80.1 | 17.9 | 56.3 | 58.9 | 58.7 | 68.0 | 69.4 | 78.3 | 22.0 |
|
|||||||||||||||||||||
Lung | 12.5 | 13.7 | 16.6 | 20.3 | 27.6 | 36.8 | 24.3 | 11.6 | 12.4 | 15.3 | 18.0 | 23.4 | 30.6 | 19.0 | 15.8 | 17.5 | 20.2 | 26.0 | 37.4 | 50.3 | 34.4 |
|
|||||||||||||||||||||
Breast | 79.2 | 83.6 | 88.7 | 91.2 | 92.8 | 93.8 | 14.5 | 77.1 | 84.3 | 87.5 | 89.9 | 90.8 | 92.5 | 15.4 | 79.3 | 83.6 | 88.7 | 91.2 | 92.8 | 93.8 | 14.5 |
|
|||||||||||||||||||||
Cervix uteri | 78.3 | 80.3 | 81.5 | 80.7 | 80.3 | 80.1 | 1.7 | - | - | - | - | - | - | - | 78.3 | 80.3 | 81.5 | 80.7 | 80.3 | 80.1 | 1.7 |
|
|||||||||||||||||||||
Corpus uteri | 82.9 | 82.0 | 84.8 | 86.5 | 87.7 | 89.3 | 6.4 | - | - | - | - | - | - | - | 82.9 | 82.0 | 84.8 | 86.5 | 87.7 | 89.3 | 6.4 |
|
|||||||||||||||||||||
Ovary | 60.1 | 59.4 | 61.7 | 61.3 | 64.9 | 64.7 | 4.6 | - | - | - | - | - | - | - | 60.1 | 59.4 | 61.7 | 61.3 | 64.9 | 64.7 | 4.6 |
|
|||||||||||||||||||||
Prostate | 59.1 | 69.4 | 81.0 | 92.0 | 94.2 | 95.2 | 36.1 | 59.1 | 69.4 | 81.0 | 92.0 | 94.2 | 95.2 | 36.1 | - | - | - | - | - | - | - |
|
|||||||||||||||||||||
Testis | 87.4 | 90.4 | 90.7 | 93.2 | 94.9 | 96.5 | 9.0 | 87.4 | 90.4 | 90.7 | 93.2 | 94.9 | 96.5 | 9.0 | - | - | - | - | - | - | - |
|
|||||||||||||||||||||
Kidney | 64.2 | 67.0 | 73.7 | 78.6 | 82.6 | 85.7 | 21.4 | 63.4 | 65.3 | 73.0 | 78.5 | 82.2 | 85.8 | 22.4 | 65.8 | 70.3 | 74.9 | 78.9 | 83.4 | 85.3 | 19.4 |
|
|||||||||||||||||||||
Bladder | 70.7 | 73.6 | 76.0 | 77.3 | 76.5 | 76.5 | 5.8 | 71.6 | 75.1 | 77.8 | 79.3 | 78.5 | 78.6 | 7.0 | 67.2 | 67.2 | 69.1 | 69.2 | 68.5 | 68.4 | 1.2 |
|
|||||||||||||||||||||
Brain and CNS | 40.4 | 39.9 | 41.1 | 42.9 | 41.8 | 40.5 | 0.1 | 39.0 | 38.7 | 40.4 | 41.4 | 40.4 | 38.4 | −0.6 | 42.3 | 41.4 | 41.9 | 44.7 | 43.4 | 43.0 | 0.7 |
|
|||||||||||||||||||||
Thyroid | 94.5 | 95.0 | 98.4 | 100.0 | 100.2 | 100.0 | 5.5 | 87.9 | 89.7 | 96.0 | 100.2 | 100.6 | 100.3 | 12.4 | 95.7 | 96.0 | 98.7 | 99.9 | 100.1 | 100.0 | 4.3 |
|
|||||||||||||||||||||
Hodgkin lymphoma | 70.2 | 71.9 | 76.7 | 81.1 | 82.3 | 87.1 | 16.9 | 69.4 | 69.3 | 74.7 | 80.8 | 81.8 | 87.1 | 17.6 | 71.5 | 77.3 | 80.7 | 81.6 | 83.3 | 87.2 | 15.7 |
|
|||||||||||||||||||||
Non-Hodgkin lymphoma | 48.3 | 51.1 | 56.0 | 59.4 | 62.9 | 65.4 | 17.1 | 46.8 | 49.6 | 55.0 | 59.2 | 62.9 | 65.9 | 19.1 | 50.7 | 53.3 | 57.5 | 59.7 | 62.8 | 64.8 | 14.1 |
|
|||||||||||||||||||||
Multiple myeloma | 23.7 | 21.0 | 29.7 | 35.0 | 41.6 | 50.7 | 27.0 | 23.2 | 19.1 | 29.9 | 35.2 | 41.2 | 51.4 | 28.2 | 24.1 | 23.2 | 29.5 | 34.7 | 42.1 | 49.8 | 25.7 |
|
|||||||||||||||||||||
Leukemia | 27.5 | 34.3 | 42.0 | 47.7 | 52.0 | 55.2 | 27.6 | 27.3 | 33.3 | 41.8 | 46.9 | 52.2 | 54.8 | 27.5 | 27.9 | 35.5 | 42.1 | 48.7 | 51.7 | 55.6 | 27.7 |
|
|||||||||||||||||||||
Other and ill-defined | 44.5 | 48.4 | 57.9 | 67.7 | 72.8 | 76.4 | 31.9 | 39.6 | 44.7 | 54.1 | 63.8 | 69.4 | 73.4 | 33.8 | 50.1 | 52.7 | 62.0 | 71.6 | 76.2 | 79.3 | 29.2 |
Site/Type | Crude prevalence rate per 100,000a) | Age-standardized prevalence rate per 100,000b) | ||||
---|---|---|---|---|---|---|
|
|
|||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 4,433.9 | 3,901.2 | 4,963.8 | 2,373.6 | 2,121.4 | 2,708.5 |
|
||||||
Lip, oral cavity, and pharynx | 61.2 | 81.8 | 40.8 | 33.4 | 45.8 | 22.3 |
|
||||||
Esophagus | 24.7 | 44.0 | 5.5 | 11.4 | 22.1 | 2.4 |
|
||||||
Stomach | 643.1 | 850.9 | 436.4 | 304.5 | 436.8 | 194.1 |
|
||||||
Colon and rectum | 569.8 | 676.7 | 463.4 | 267.5 | 350.3 | 199.5 |
|
||||||
Liver | 151.8 | 227.4 | 76.6 | 77.2 | 122.3 | 36.0 |
|
||||||
Gallbladderc) | 52.0 | 53.8 | 50.2 | 22.9 | 27.0 | 19.7 |
|
||||||
Pancreas | 32.0 | 32.4 | 31.6 | 16.3 | 17.4 | 15.6 |
|
||||||
Larynx | 23.9 | 45.0 | 2.8 | 10.9 | 22.6 | 1.2 |
|
||||||
Lung | 216.6 | 258.7 | 174.7 | 101.5 | 131.0 | 78.8 |
|
||||||
Breast | 545.2 | 4.0 | 1,083.6 | 307.6 | 2.1 | 606.2 |
|
||||||
Cervix uteri | 117.8 | - | 234.9 | 65.2 | - | 128.0 |
|
||||||
Corpus uteri | 65.8 | - | 131.2 | 37.1 | - | 73.2 |
|
||||||
Ovary | 50.0 | - | 99.8 | 30.8 | - | 61.4 |
|
||||||
Prostate | 234.5 | 470.3 | - | 96.5 | 223.9 | - |
|
||||||
Testis | 8.5 | 17.1 | - | 7.6 | 14.8 | - |
|
||||||
Kidney | 106.4 | 144.4 | 68.6 | 57.9 | 82.0 | 35.8 |
|
||||||
Bladder | 81.5 | 133.1 | 30.1 | 35.7 | 66.5 | 11.6 |
|
||||||
Brain and CNS | 26.1 | 26.9 | 25.3 | 21.2 | 22.5 | 19.9 |
|
||||||
Thyroid | 953.6 | 357.5 | 1,546.6 | 587.8 | 226.8 | 947.2 |
|
||||||
Hodgkin lymphoma | 7.1 | 8.8 | 5.4 | 5.7 | 6.8 | 4.6 |
|
||||||
Non-Hodgkin lymphoma | 79.6 | 90.5 | 68.7 | 50.5 | 60.4 | 41.1 |
|
||||||
Multiple myeloma | 16.2 | 17.1 | 15.3 | 7.9 | 9.0 | 7.0 |
|
||||||
Leukemia | 52.9 | 58.8 | 47.0 | 46.0 | 51.4 | 40.6 |
|
||||||
Other and ill-defined | 313.7 | 302.0 | 325.3 | 170.4 | 180.1 | 162.4 |
CNS, central nervous system.
a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times,
b) Age-adjusted using the Segi’s world standard population,
c) Includes the gallbladder and other/unspecified parts of the biliary tract.
Cancer incidence, deaths and prevalence by sex in Korea, 2020
Site/Type | New cases | Deaths | Prevalent cases | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
Both sexes | Men | Women | Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 247,952 | 130,618 | 117,334 | 82,204 | 50,817 | 31,387 | 2,276,792 | 998,948 | 1,277,844 |
| |||||||||
Lip, oral cavity, and pharynx | 4,064 | 2,892 | 1,172 | 1,283 | 972 | 311 | 31,447 | 20,948 | 10,499 |
| |||||||||
Esophagus | 2,748 | 2,451 | 297 | 1,564 | 1,404 | 160 | 12,684 | 11,274 | 1,410 |
| |||||||||
Stomach | 26,662 | 17,869 | 8,793 | 7,510 | 4,807 | 2,703 | 330,217 | 217,881 | 112,336 |
| |||||||||
Colon and rectum | 27,877 | 16,485 | 11,392 | 8,869 | 5,029 | 3,840 | 292,586 | 173,285 | 119,301 |
| |||||||||
Liver | 15,152 | 11,150 | 4,002 | 10,565 | 7,812 | 2,753 | 77,958 | 58,239 | 19,719 |
| |||||||||
Gallbladder |
7,452 | 4,012 | 3,440 | 5,192 | 2,784 | 2,408 | 26,685 | 13,770 | 12,915 |
| |||||||||
Pancreas | 8,414 | 4,324 | 4,090 | 6,775 | 3,452 | 3,323 | 16,415 | 8,293 | 8,122 |
| |||||||||
Larynx | 1,203 | 1,141 | 62 | 321 | 310 | 11 | 12,251 | 11,524 | 727 |
| |||||||||
Lung | 28,949 | 19,657 | 9,292 | 18,673 | 13,824 | 4,849 | 111,208 | 66,240 | 44,968 |
| |||||||||
Breast | 24,923 | 117 | 24,806 | 2,745 | 20 | 2,725 | 279,965 | 1,012 | 278,953 |
| |||||||||
Cervix uteri | 2,998 | - | 2,998 | 810 | - | 810 | 60,467 | - | 60,467 |
| |||||||||
Corpus uteri | 3,492 | - | 3,492 | 378 | - | 378 | 33,785 | - | 33,785 |
| |||||||||
Ovary | 2,947 | - | 2,947 | 1,369 | - | 1,369 | 25,683 | - | 25,683 |
| |||||||||
Prostate | 16,815 | 16,815 | - | 2,194 | 2,194 | - | 120,423 | 120,423 | - |
| |||||||||
Testis | 361 | 361 | - | 14 | 14 | - | 4,385 | 4,385 | - |
| |||||||||
Kidney | 5,946 | 4,135 | 1,811 | 1,076 | 764 | 312 | 54,652 | 36,986 | 17,666 |
| |||||||||
Bladder | 4,753 | 3,826 | 927 | 1,593 | 1,235 | 358 | 41,835 | 34,085 | 7,750 |
| |||||||||
Brain and CNS | 1,970 | 1,056 | 914 | 1,437 | 784 | 653 | 13,411 | 6,888 | 6,523 |
| |||||||||
Thyroid | 29,180 | 7,458 | 21,722 | 365 | 128 | 237 | 489,688 | 91,546 | 398,142 |
| |||||||||
Hodgkin lymphoma | 323 | 214 | 109 | 48 | 30 | 18 | 3,657 | 2,255 | 1,402 |
| |||||||||
Non-Hodgkin lymphoma | 5,636 | 3,248 | 2,388 | 1,926 | 1,106 | 820 | 40,853 | 23,163 | 17,690 |
| |||||||||
Multiple myeloma | 1,747 | 961 | 786 | 976 | 514 | 462 | 8,307 | 4,381 | 3,926 |
| |||||||||
Leukemia | 3,605 | 2,020 | 1,585 | 1,825 | 1,048 | 777 | 27,157 | 15,045 | 12,112 |
| |||||||||
Other and ill-defined | 20,735 | 10,426 | 10,309 | 4,696 | 2,586 | 2,110 | 161,073 | 77,325 | 83,748 |
CNS, central nervous system.
a)Limited-duration prevalent cases on January 1, 2020. These are patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times,
b)Includes the gallbladder and other/unspecified parts of the biliary tract.
Crude and age-standardized cancer incidence rates by sex in Korea, 2020
Site/Type | Crude incidence rate per 100,000 | Age-standardized incidence rate per 100,000 | ||||
---|---|---|---|---|---|---|
|
| |||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 482.9 | 510.1 | 455.8 | 262.2 | 279.1 | 257.3 |
| ||||||
Lip, oral cavity, and pharynx | 7.9 | 11.3 | 4.6 | 4.4 | 6.4 | 2.6 |
| ||||||
Esophagus | 5.4 | 9.6 | 1.2 | 2.6 | 4.9 | 0.5 |
| ||||||
Stomach | 51.9 | 69.8 | 34.2 | 25.7 | 36.9 | 15.9 |
| ||||||
Colon and rectum | 54.3 | 64.4 | 44.3 | 27.1 | 34.8 | 20.2 |
| ||||||
Liver | 29.5 | 43.5 | 15.5 | 14.5 | 23.2 | 6.7 |
| ||||||
Gallbladder |
14.5 | 15.7 | 13.4 | 6.2 | 7.7 | 4.9 |
| ||||||
Pancreas | 16.4 | 16.9 | 15.9 | 7.6 | 8.7 | 6.7 |
| ||||||
Larynx | 2.3 | 4.5 | 0.2 | 1.1 | 2.3 | 0.1 |
| ||||||
Lung | 56.4 | 76.8 | 36.1 | 25.8 | 38.5 | 15.9 |
| ||||||
Breast | 48.5 | 0.5 | 96.4 | 30.1 | 0.2 | 59.9 |
| ||||||
Cervix uteri | 5.8 | - | 11.6 | 3.7 | - | 7.3 |
| ||||||
Corpus uteri | 6.8 | - | 13.6 | 4.2 | - | 8.4 |
| ||||||
Ovary | 5.7 | - | 11.4 | 3.5 | - | 7.0 |
| ||||||
Prostate | 32.7 | 65.7 | - | 14.7 | 32.5 | - |
| ||||||
Testis | 0.7 | 1.4 | - | 0.7 | 1.4 | - |
| ||||||
Kidney | 11.6 | 16.1 | 7.0 | 6.6 | 9.4 | 3.9 |
| ||||||
Bladder | 9.3 | 14.9 | 3.6 | 4.1 | 7.5 | 1.4 |
| ||||||
Brain and CNS | 3.8 | 4.1 | 3.6 | 2.8 | 3.2 | 2.4 |
| ||||||
Thyroid | 56.8 | 29.1 | 84.4 | 41.3 | 20.9 | 62.4 |
| ||||||
Hodgkin lymphoma | 0.6 | 0.8 | 0.4 | 0.5 | 0.7 | 0.4 |
| ||||||
Non-Hodgkin lymphoma | 11.0 | 12.7 | 9.3 | 6.6 | 8.1 | 5.2 |
| ||||||
Multiple myeloma | 3.4 | 3.8 | 3.1 | 1.6 | 1.9 | 1.4 |
| ||||||
Leukemia | 7.0 | 7.9 | 6.2 | 5.4 | 6.1 | 4.8 |
| ||||||
Other and ill-defined | 40.4 | 40.7 | 40.0 | 21.4 | 23.7 | 19.4 |
CNS, central nervous system.
a)Age-adjusted using the Segi’s world standard population,
b)Includes the gallbladder and other/unspecified parts of the biliary tract.
The top 10 leading causes of death in Korea, 2020
Rank | Cause of death | No. of deaths | Percentage of all deaths | Age-standardized death rate per 100,000 |
---|---|---|---|---|
All causes | 304,948 | 100.0 | 249.4 | |
1 | Cancer | 82,204 | 27.0 | 69.9 |
2 | Heart disease | 32,347 | 10.6 | 24.2 |
3 | Cerebrovascular disease | 21,860 | 7.2 | 16.2 |
4 | Pneumonia | 22,257 | 7.3 | 14.8 |
5 | Intentional self-harm (suicide) | 13,195 | 4.3 | 17.9 |
6 | Diabetes mellitus | 8,456 | 2.8 | 6.3 |
7 | Disease of liver | 6,979 | 2.3 | 7.1 |
8 | Chronic lower respiratory diseases | 5,668 | 1.9 | 3.8 |
9 | Hypertensive diseases | 6,100 | 2.0 | 4.0 |
10 | Transport accidents | 3,947 | 1.3 | 4.6 |
Others | 101,935 | 33.4 | 80.5 |
Source: Mortality Data, 2020, Statistics Korea [
a)Age-adjusted using the Segi’s world standard population.
Crude and age-standardized cancer mortality rates by sex in Korea, 2020
Site/Type | Crude mortality rate per 100,000 | Age-standardized mortality rate per 100,000 | ||||
---|---|---|---|---|---|---|
|
| |||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 160.1 | 198.5 | 121.9 | 69.9 | 99.4 | 47.8 |
| ||||||
Lip, oral cavity, and pharynx | 2.5 | 3.8 | 1.2 | 1.2 | 2.0 | 0.5 |
| ||||||
Esophagus | 3.0 | 5.5 | 0.6 | 1.4 | 2.7 | 0.3 |
| ||||||
Stomach | 14.6 | 18.8 | 10.5 | 6.4 | 9.5 | 4.1 |
| ||||||
Colon and rectum | 17.3 | 19.6 | 14.9 | 7.2 | 9.9 | 5.2 |
| ||||||
Liver | 20.6 | 30.5 | 10.7 | 9.4 | 15.7 | 3.9 |
| ||||||
Gallbladder |
10.1 | 10.9 | 9.4 | 4.0 | 5.2 | 3.1 |
| ||||||
Pancreas | 13.2 | 13.5 | 12.9 | 5.7 | 6.8 | 4.7 |
| ||||||
Larynx | 0.6 | 1.2 | 0.0 | 0.3 | 0.6 | 0.0 |
| ||||||
Lung | 36.4 | 54.0 | 18.8 | 14.9 | 25.9 | 6.6 |
| ||||||
Breast | 5.3 | 0.1 | 10.6 | 2.9 | 0.0 | 5.6 |
| ||||||
Cervix uteri | 1.6 | - | 3.1 | 0.8 | - | 1.5 |
| ||||||
Corpus uteri | 0.7 | - | 1.5 | 0.4 | - | 0.7 |
| ||||||
Ovary | 2.7 | - | 5.3 | 1.3 | - | 2.6 |
| ||||||
Prostate | 4.3 | 8.6 | - | 1.5 | 4.0 | - |
| ||||||
Testis | 0.0 | 0.1 | - | 0.0 | 0.0 | - |
| ||||||
Kidney | 2.1 | 3.0 | 1.2 | 0.9 | 1.5 | 0.4 |
| ||||||
Bladder | 3.1 | 4.8 | 1.4 | 1.2 | 2.3 | 0.4 |
| ||||||
Brain and CNS | 2.8 | 3.1 | 2.5 | 1.6 | 1.9 | 1.3 |
| ||||||
Thyroid | 0.7 | 0.5 | 0.9 | 0.3 | 0.2 | 0.3 |
| ||||||
Hodgkin lymphoma | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 |
| ||||||
Non-Hodgkin lymphoma | 3.8 | 4.3 | 3.2 | 1.7 | 2.3 | 1.2 |
| ||||||
Multiple myeloma | 1.9 | 2.0 | 1.8 | 0.8 | 1.0 | 0.6 |
| ||||||
Leukemia | 3.6 | 4.1 | 3.0 | 1.9 | 2.4 | 1.5 |
| ||||||
Other and ill-defined | 9.1 | 10.1 | 8.2 | 4.2 | 5.5 | 3.2 |
CNS, central nervous system.
a)Age-adjusted using the Segi’s world standard population,
b)Includes the gallbladder and other/unspecified parts of the biliary tract.
Trends in cancer incidence and mortality rates from 1999 to 2020 in Korea, both sexes
Site/Type | Incidence | Mortality | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||
1999 | 2020 | Trend 1 | Trend 2 | Trend 3 | 1999 | 2020 | Trend 1 | Trend 2 | Trend 3 | |||||||
|
|
|
|
|
| |||||||||||
Years | APC | Years | APC | Years | APC | Years | APC | Years | APC | Years | APC | |||||
All sites | 212.1 | 262.2 | 1999–2012 | 3.3 |
2012–2015 | −5.0 |
2015–2020 | 0.3 | 115.1 | 69.9 | 1999–2002 | 0.9 | 2002–2013 | −2.7 |
2013–2020 | −3.3 |
| ||||||||||||||||
Lip, oral cavity, and pharynx | 3.6 | 4.4 | 1999–2020 | 0.7 |
- | - | - | - | 1.1 | 1.2 | 1999–2020 | −1.8 |
- | - | - | - |
| ||||||||||||||||
Esophagus | 4.1 | 2.6 | 1999–2020 | −2.0 |
- | - | - | - | 3.1 | 1.4 | 1999–2020 | −4.3 |
- | - | - | - |
| ||||||||||||||||
Stomach | 43.6 | 25.7 | 1999–2011 | −0.2 | 2011–2020 | −4.8 |
- | - | 23.9 | 6.4 | 1999–2002 | −2.5 |
2002–2010 | −6.4 |
2010–2020 | −7.2 |
| ||||||||||||||||
Colon and rectum | 20.5 | 27.1 | 1999–2006 | 7.3 |
2006–2011 | 2.9 |
2011–2020 | −3.8 |
7.8 | 7.2 | 1999–2003 | 6.5 |
2003–2012 | −0.5 |
2012–2020 | −3.6 |
| ||||||||||||||||
Liver | 27.9 | 14.5 | 1999–2010 | −1.7 |
2010–2020 | −4.3 |
- | - | 20.6 | 9.4 | 1999–2002 | 0.6 | 2002–2014 | −3.7 |
2014–2020 | −5.9 |
| ||||||||||||||||
Gallbladder |
6.5 | 6.2 | 1999–2004 | 1.4 | 2004–2018 | −0.3 | 2018–2020 | −3.6 | 5.2 | 4.0 | 1999–2001 | 7.7 | 2001–2013 | −2.9 |
2013–2020 | −0.7 |
| ||||||||||||||||
Pancreas | 5.6 | 7.6 | 1999–2020 | 1.6 |
- | - | - | - | 5.5 | 5.7 | 1999–2020 | 0.1 | - | - | - | - |
| ||||||||||||||||
Larynx | 2.4 | 1.1 | 1999–2020 | −3.5 |
- | - | - | - | 1.6 | 0.3 | 1999–2005 | −8.1 |
2005–2008 | −15.5 |
2008–2020 | −7.2 |
| ||||||||||||||||
Lung | 28.5 | 25.8 | 1999–2020 | −0.3 |
- | - | - | - | 22.5 | 14.9 | 1999–2001 | 3.6 | 2001–2013 | −1.9 |
2013–2020 | −3.6 |
| ||||||||||||||||
Breast | 11.0 | 30.1 | 1999–2008 | 6.3 |
2008–2020 | 4.1 |
- | - | 2.3 | 2.9 | 1999–2004 | 2.9 |
2004–2020 | 0.8 |
- | - |
| ||||||||||||||||
Cervix uteri | 8.6 | 3.7 | 1999–2007 | −4.6 |
2007–2020 | −3.2 |
- | - | 1.4 | 0.8 | 1999–2003 | 10.1 |
2003–2008 | −7.1 |
2008–2020 | −4.2 |
| ||||||||||||||||
Corpus uteri | 1.4 | 4.2 | 1999–2020 | 5.1 |
- | - | - | - | 0.1 | 0.4 | 1999–2003 | 36.1 |
2003–2020 | 2.3 |
- | - |
| ||||||||||||||||
Ovary | 2.7 | 3.5 | 1999–2020 | 1.7 |
- | - | - | - | 0.9 | 1.3 | 1999–2020 | 0.6 |
- | - | - | |
| ||||||||||||||||
Prostate | 3.1 | 14.7 | 1999–2009 | 14.8 |
2009–2015 | 1 | 2015–2020 | 5.6 |
0.9 | 1.5 | 1999–2002 | 15.0 |
2002–2010 | 1.9 |
2010–2020 | −1.1 |
| ||||||||||||||||
Testis | 0.3 | 0.7 | 1999–2020 | 4.8 |
- | - | - | - | 0.0 | 0.0 | 1999–2020 | −2.4 |
- | - | - | - |
| ||||||||||||||||
Kidney | 3.0 | 6.6 | 1999–2009 | 6.4 |
2009–2020 | 2.2 |
- | - | 1.1 | 0.9 | 1999–2016 | −0.2 | 2016–2020 | −4.7 |
- | - |
| ||||||||||||||||
Bladder | 4.7 | 4.1 | 1999–2004 | 1.9 | 2004–2020 | −1.1 |
- | - | 1.3 | 1.2 | 1999–2002 | 9.3 |
2002–2005 | −6.0 | 2005–2020 | −1.5 |
| ||||||||||||||||
Brain and CNS | 2.9 | 2.8 | 1999–2020 | 0.1 | - | - | - | - | 1.9 | 1.6 | 1999–2003 | 4.1 |
2003–2008 | −4.3 |
2008–2020 | −0.8 |
| ||||||||||||||||
Thyroid | 6.5 | 41.3 | 1999–2011 | 22.4 |
2011–2016 | −12.1 |
2016–2020 | 4.5 | 0.4 | 0.3 | 1999–2003 | 7.4 |
2003–2020 | −4.5 |
- | - |
| ||||||||||||||||
Hodgkin lymphoma | 0.3 | 0.5 | 1999–2011 | 4.9 |
2011–2020 | 1.6 | - | - | 0.0 | 0.0 | 1999–2004 | 24.7 |
2004–2020 | −2.6 |
- | - |
| ||||||||||||||||
Non-Hodgkin lymphoma | 4.3 | 6.6 | 1999–2020 | 2.3 |
- | - | - | - | 2.1 | 1.7 | 1999–2020 | −1.1 |
- | - | - | - |
| ||||||||||||||||
Multiple myeloma | 1.0 | 1.6 | 1999–2013 | 3.7 |
2013–2020 | 0.3 | - | - | 0.6 | 0.8 | 1999–2003 | 12.8 |
2003–2016 | 0.8 | 2016–2020 | −6.0 |
| ||||||||||||||||
Leukemia | 4.7 | 5.4 | 1999–2020 | 0.9 |
- | - | - | - | 2.9 | 1.9 | 1999–2020 | −1.9 |
- | - | - | - |
| ||||||||||||||||
Other and ill-defined | 15.0 | 21.4 | 1999–2018 | 2.3 |
2018–2020 | −2.1 | - | - | 7.8 | 4.2 | 1999–2020 | −2.7 |
- | - | - | - |
APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the Segi’s world standard population.
a)Significantly different from zero (p < 0.05),
b)Includes the gallbladder and other/unspecified parts of the biliary tract.
Trends in the 5-year relative survival rates (%) by sex and year of diagnosis from 1993 to 2020 in Korea
Site/Type | Both sexes | Men | Women | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||||||||||
1993–1995 | 1996–2000 | 2001–2005 | 2006–2010 | 2011–2015 | 2016–2020 | Change |
1993–1995 | 1996–2000 | 2001–2005 | 2006–2010 | 2011–2015 | 2016–2020 | Change |
1993–1995 | 1996–2000 | 2001–2005 | 2006–2010 | 2011–2015 | 2016–2020 | Change | |
All sites | 42.9 | 45.2 | 54.1 | 65.5 | 70.7 | 71.5 | 28.6 | 33.2 | 36.4 | 45.6 | 56.9 | 63.1 | 65.5 | 32.3 | 55.2 | 56.4 | 64.3 | 74.4 | 78.3 | 77.8 | 22.6 |
| |||||||||||||||||||||
All sites excluding thyroid | 41.2 | 43.4 | 50.9 | 59.1 | 64.3 | 67.3 | 26.1 | 32.7 | 35.9 | 44.7 | 54.6 | 60.4 | 63.4 | 30.7 | 52.6 | 53.5 | 59.1 | 65.0 | 69.4 | 72.2 | 19.6 |
| |||||||||||||||||||||
Lip, oral cavity, and pharynx | 42.2 | 47.4 | 54.5 | 61.1 | 65.5 | 69.4 | 27.2 | 36.6 | 41.7 | 49.7 | 56.9 | 61.8 | 66.7 | 30.1 | 59.4 | 64.5 | 68.1 | 72.1 | 74.5 | 75.8 | 16.5 |
| |||||||||||||||||||||
Esophagus | 14.0 | 15.7 | 21.6 | 30.0 | 36.6 | 42.2 | 28.2 | 13.0 | 14.7 | 20.8 | 29.4 | 36.2 | 41.8 | 28.7 | 25.0 | 25.9 | 29.8 | 37.3 | 39.6 | 45.6 | 20.6 |
| |||||||||||||||||||||
Stomach | 43.9 | 47.3 | 58.0 | 68.4 | 75.9 | 78.0 | 34.1 | 44.0 | 47.6 | 58.7 | 69.1 | 76.8 | 78.9 | 35.0 | 43.7 | 46.8 | 56.6 | 67.0 | 74.0 | 76.0 | 32.3 |
| |||||||||||||||||||||
Colon and rectum | 56.2 | 58.9 | 66.9 | 73.9 | 76.1 | 74.3 | 18.1 | 56.7 | 59.8 | 68.8 | 75.8 | 77.8 | 75.6 | 19.0 | 55.7 | 57.7 | 64.5 | 71.1 | 73.6 | 72.3 | 16.7 |
| |||||||||||||||||||||
Liver | 11.8 | 14.1 | 20.5 | 28.3 | 34.4 | 38.7 | 26.9 | 10.8 | 13.8 | 20.4 | 28.3 | 35.0 | 39.1 | 28.2 | 15.1 | 15.1 | 20.9 | 28.3 | 32.8 | 37.6 | 22.6 |
| |||||||||||||||||||||
Gallbladder |
18.7 | 20.7 | 23.1 | 26.9 | 28.8 | 29.0 | 10.4 | 18.0 | 21.1 | 23.5 | 27.8 | 29.5 | 29.8 | 11.7 | 19.3 | 20.3 | 22.7 | 26.0 | 28.0 | 28.2 | 8.9 |
| |||||||||||||||||||||
Pancreas | 10.6 | 8.7 | 8.4 | 8.6 | 10.9 | 15.2 | 4.6 | 10.0 | 8.3 | 8.4 | 8.3 | 10.3 | 14.2 | 4.2 | 11.5 | 9.3 | 8.4 | 8.9 | 11.6 | 16.2 | 4.7 |
| |||||||||||||||||||||
Larynx | 61.6 | 63.3 | 66.5 | 73.2 | 75.3 | 80.0 | 18.3 | 62.2 | 63.7 | 67.1 | 73.5 | 75.7 | 80.1 | 17.9 | 56.3 | 58.9 | 58.7 | 68.0 | 69.4 | 78.3 | 22.0 |
| |||||||||||||||||||||
Lung | 12.5 | 13.7 | 16.6 | 20.3 | 27.6 | 36.8 | 24.3 | 11.6 | 12.4 | 15.3 | 18.0 | 23.4 | 30.6 | 19.0 | 15.8 | 17.5 | 20.2 | 26.0 | 37.4 | 50.3 | 34.4 |
| |||||||||||||||||||||
Breast | 79.2 | 83.6 | 88.7 | 91.2 | 92.8 | 93.8 | 14.5 | 77.1 | 84.3 | 87.5 | 89.9 | 90.8 | 92.5 | 15.4 | 79.3 | 83.6 | 88.7 | 91.2 | 92.8 | 93.8 | 14.5 |
| |||||||||||||||||||||
Cervix uteri | 78.3 | 80.3 | 81.5 | 80.7 | 80.3 | 80.1 | 1.7 | - | - | - | - | - | - | - | 78.3 | 80.3 | 81.5 | 80.7 | 80.3 | 80.1 | 1.7 |
| |||||||||||||||||||||
Corpus uteri | 82.9 | 82.0 | 84.8 | 86.5 | 87.7 | 89.3 | 6.4 | - | - | - | - | - | - | - | 82.9 | 82.0 | 84.8 | 86.5 | 87.7 | 89.3 | 6.4 |
| |||||||||||||||||||||
Ovary | 60.1 | 59.4 | 61.7 | 61.3 | 64.9 | 64.7 | 4.6 | - | - | - | - | - | - | - | 60.1 | 59.4 | 61.7 | 61.3 | 64.9 | 64.7 | 4.6 |
| |||||||||||||||||||||
Prostate | 59.1 | 69.4 | 81.0 | 92.0 | 94.2 | 95.2 | 36.1 | 59.1 | 69.4 | 81.0 | 92.0 | 94.2 | 95.2 | 36.1 | - | - | - | - | - | - | - |
| |||||||||||||||||||||
Testis | 87.4 | 90.4 | 90.7 | 93.2 | 94.9 | 96.5 | 9.0 | 87.4 | 90.4 | 90.7 | 93.2 | 94.9 | 96.5 | 9.0 | - | - | - | - | - | - | - |
| |||||||||||||||||||||
Kidney | 64.2 | 67.0 | 73.7 | 78.6 | 82.6 | 85.7 | 21.4 | 63.4 | 65.3 | 73.0 | 78.5 | 82.2 | 85.8 | 22.4 | 65.8 | 70.3 | 74.9 | 78.9 | 83.4 | 85.3 | 19.4 |
| |||||||||||||||||||||
Bladder | 70.7 | 73.6 | 76.0 | 77.3 | 76.5 | 76.5 | 5.8 | 71.6 | 75.1 | 77.8 | 79.3 | 78.5 | 78.6 | 7.0 | 67.2 | 67.2 | 69.1 | 69.2 | 68.5 | 68.4 | 1.2 |
| |||||||||||||||||||||
Brain and CNS | 40.4 | 39.9 | 41.1 | 42.9 | 41.8 | 40.5 | 0.1 | 39.0 | 38.7 | 40.4 | 41.4 | 40.4 | 38.4 | −0.6 | 42.3 | 41.4 | 41.9 | 44.7 | 43.4 | 43.0 | 0.7 |
| |||||||||||||||||||||
Thyroid | 94.5 | 95.0 | 98.4 | 100.0 | 100.2 | 100.0 | 5.5 | 87.9 | 89.7 | 96.0 | 100.2 | 100.6 | 100.3 | 12.4 | 95.7 | 96.0 | 98.7 | 99.9 | 100.1 | 100.0 | 4.3 |
| |||||||||||||||||||||
Hodgkin lymphoma | 70.2 | 71.9 | 76.7 | 81.1 | 82.3 | 87.1 | 16.9 | 69.4 | 69.3 | 74.7 | 80.8 | 81.8 | 87.1 | 17.6 | 71.5 | 77.3 | 80.7 | 81.6 | 83.3 | 87.2 | 15.7 |
| |||||||||||||||||||||
Non-Hodgkin lymphoma | 48.3 | 51.1 | 56.0 | 59.4 | 62.9 | 65.4 | 17.1 | 46.8 | 49.6 | 55.0 | 59.2 | 62.9 | 65.9 | 19.1 | 50.7 | 53.3 | 57.5 | 59.7 | 62.8 | 64.8 | 14.1 |
| |||||||||||||||||||||
Multiple myeloma | 23.7 | 21.0 | 29.7 | 35.0 | 41.6 | 50.7 | 27.0 | 23.2 | 19.1 | 29.9 | 35.2 | 41.2 | 51.4 | 28.2 | 24.1 | 23.2 | 29.5 | 34.7 | 42.1 | 49.8 | 25.7 |
| |||||||||||||||||||||
Leukemia | 27.5 | 34.3 | 42.0 | 47.7 | 52.0 | 55.2 | 27.6 | 27.3 | 33.3 | 41.8 | 46.9 | 52.2 | 54.8 | 27.5 | 27.9 | 35.5 | 42.1 | 48.7 | 51.7 | 55.6 | 27.7 |
| |||||||||||||||||||||
Other and ill-defined | 44.5 | 48.4 | 57.9 | 67.7 | 72.8 | 76.4 | 31.9 | 39.6 | 44.7 | 54.1 | 63.8 | 69.4 | 73.4 | 33.8 | 50.1 | 52.7 | 62.0 | 71.6 | 76.2 | 79.3 | 29.2 |
CNS, central nervous system.
a)Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2016 to 2020,
b)Includes the gallbladder and other/unspecified parts of the biliary tract.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2020 in Korea
Site/Type | Crude prevalence rate per 100,000 |
Age-standardized prevalence rate per 100,000 | ||||
---|---|---|---|---|---|---|
|
| |||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 4,433.9 | 3,901.2 | 4,963.8 | 2,373.6 | 2,121.4 | 2,708.5 |
| ||||||
Lip, oral cavity, and pharynx | 61.2 | 81.8 | 40.8 | 33.4 | 45.8 | 22.3 |
| ||||||
Esophagus | 24.7 | 44.0 | 5.5 | 11.4 | 22.1 | 2.4 |
| ||||||
Stomach | 643.1 | 850.9 | 436.4 | 304.5 | 436.8 | 194.1 |
| ||||||
Colon and rectum | 569.8 | 676.7 | 463.4 | 267.5 | 350.3 | 199.5 |
| ||||||
Liver | 151.8 | 227.4 | 76.6 | 77.2 | 122.3 | 36.0 |
| ||||||
Gallbladder |
52.0 | 53.8 | 50.2 | 22.9 | 27.0 | 19.7 |
| ||||||
Pancreas | 32.0 | 32.4 | 31.6 | 16.3 | 17.4 | 15.6 |
| ||||||
Larynx | 23.9 | 45.0 | 2.8 | 10.9 | 22.6 | 1.2 |
| ||||||
Lung | 216.6 | 258.7 | 174.7 | 101.5 | 131.0 | 78.8 |
| ||||||
Breast | 545.2 | 4.0 | 1,083.6 | 307.6 | 2.1 | 606.2 |
| ||||||
Cervix uteri | 117.8 | - | 234.9 | 65.2 | - | 128.0 |
| ||||||
Corpus uteri | 65.8 | - | 131.2 | 37.1 | - | 73.2 |
| ||||||
Ovary | 50.0 | - | 99.8 | 30.8 | - | 61.4 |
| ||||||
Prostate | 234.5 | 470.3 | - | 96.5 | 223.9 | - |
| ||||||
Testis | 8.5 | 17.1 | - | 7.6 | 14.8 | - |
| ||||||
Kidney | 106.4 | 144.4 | 68.6 | 57.9 | 82.0 | 35.8 |
| ||||||
Bladder | 81.5 | 133.1 | 30.1 | 35.7 | 66.5 | 11.6 |
| ||||||
Brain and CNS | 26.1 | 26.9 | 25.3 | 21.2 | 22.5 | 19.9 |
| ||||||
Thyroid | 953.6 | 357.5 | 1,546.6 | 587.8 | 226.8 | 947.2 |
| ||||||
Hodgkin lymphoma | 7.1 | 8.8 | 5.4 | 5.7 | 6.8 | 4.6 |
| ||||||
Non-Hodgkin lymphoma | 79.6 | 90.5 | 68.7 | 50.5 | 60.4 | 41.1 |
| ||||||
Multiple myeloma | 16.2 | 17.1 | 15.3 | 7.9 | 9.0 | 7.0 |
| ||||||
Leukemia | 52.9 | 58.8 | 47.0 | 46.0 | 51.4 | 40.6 |
| ||||||
Other and ill-defined | 313.7 | 302.0 | 325.3 | 170.4 | 180.1 | 162.4 |
CNS, central nervous system.
a)Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times,
b)Age-adjusted using the Segi’s world standard population,
c)Includes the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system. Limited-duration prevalent cases on January 1, 2020. These are patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times, Includes the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system. Age-adjusted using the Segi’s world standard population, Includes the gallbladder and other/unspecified parts of the biliary tract.
Source: Mortality Data, 2020, Statistics Korea [ Age-adjusted using the Segi’s world standard population.
CNS, central nervous system. Age-adjusted using the Segi’s world standard population, Includes the gallbladder and other/unspecified parts of the biliary tract.
APC, annual percentage change; CNS, central nervous system. APC was calculated using age-standardized incidence data based on the Segi’s world standard population. Significantly different from zero (p < 0.05), Includes the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system. Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2016 to 2020, Includes the gallbladder and other/unspecified parts of the biliary tract.
CNS, central nervous system. Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times, Age-adjusted using the Segi’s world standard population, Includes the gallbladder and other/unspecified parts of the biliary tract.